MASH as an emerging cause of hepatocellular carcinoma: current knowledge and future perspectives
Hepatocellular carcinoma is one of the deadliest and fastest‐growing cancers. Among HCC etiologies, metabolic dysfunction‐associated fatty liver disease (MAFLD) has served as a major HCC driver due to its great potential for increasing cirrhosis. The obesogenic environment fosters a positive energy...
Saved in:
Main Authors: | Michael Karin, Ju Youn Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-02-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13685 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single-Cell RNA Sequencing Reveals Macrophage Dynamics During MASH in <i>Leptin</i>-Deficient Rats
by: Xiaoming Xin, et al.
Published: (2025-01-01) -
Validation of the Chronic Liver Disease Questionnaire for MASH (CLDQ-MASH)
by: Zobair M. Younossi, et al.
Published: (2025-03-01) -
A (re)configuração da linguagem nos mash ups literários de Machado de Assis
by: Rebeca Fabiana Ferreira da Silva Santos, et al.
Published: (2022-01-01) -
FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management
by: Muhammad Mazhar Azam, et al.
Published: (2024-12-01) -
Genetic polymorphism of hepatitis C virus and risk of hepatocellular carcinoma
by: S. N. Mammayev, et al.
Published: (2014-09-01)